HPV Vaccination in Japan (.pdf, 4.4 MB):
- Describes major events with regards to the HPV vaccine controversy in Japan since May 2014, highlighting long-term implications of the rapid drop in vaccination coverage and recommending how to best move forward.
- Two addendums explore global perspectives on the current situation in Japan and examine examples of how other countries have dealt with concerns and opposition to the HPV vaccine.
HPV Vaccination in Africa: lessons learned from a pilot program in Uganda (2011) (.pdf, 1 MB):
Uganda is one of the countries chosen by PATH as a site for the HPV Vaccines project. In Uganda, cervical cancer accounts for 40 percent of all cancers recorded by the cancer registry, and over 80 percent of women with cervical cancer are diagnosed with advanced disease. Through a demonstration project conducted in 2008–2009 in selected districts, HPV vaccine was made available to more than 10,000 girls.
HPV Vaccination in Latin America. Lessons learnt from a pilot program in Peru (2010) (.pdf, 1 MB):
Peru has some of the highest cervical cancer incidence and mortality rates of the Latin American and Caribbean region. Through a demonstration project in 2008–2009 in selected areas of the country, HPV vaccine was made available to all girls aged nine years or older in grade five.
HPV Vaccination in Southeast Asia. Lessons learned from a pilot program in Vietnam (2012) (.pdf, 2.3 MB)
Through a vaccination demonstration project carried out from 2008 to 2010, more than 6,300 girls aged 11 years (or in grade 6) received all three doses of the vaccine. Two vaccine delivery strategies were implemented:
- In the first, vaccinations were conducted at schools for girls enrolled in grade 6, with active outreach later in health centers to vaccinate girls who had been missed.
- In the second, girls aged 11 years were vaccinated at commune health centers.
Anishinaabek Cervical Cancer Screening study, Canada (2015) (.pdf, 1.7 MB)
First Nations women in Ontario (Canada) are approximately twice as likely to get cervical cancer as the mainstream population Picture Click on Report cover image above to view a copy. The Anishinaabek Cervical Cancer Screening Study (ACCSS) is a research study based in Thunder Bay, Ontario, Canada. Researchers think that by increasing cervical cancer screening in First Nations communities, the number of new cases of cervical cancer will decrease. ACCSS aims to find a culturally safe way to promote cervical screening in these Indigenous communities. Health care providers and women from these communities stress that culturally sensitive education is needed.